Investors Investors

Stock Quote

NASDAQ: PGNX
$8.68
+ 0.01
2:28 PM ET on December 2

Press Releases

All Releases
View Summary Progenics Pharmaceuticals to Present at Upcoming Investor Conferences
Nov 8, 2016
PDF 12.2 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces Third Quarter 2016 Financial Results and Business Update
Nov 7, 2016
PDF 74.3 KB Add to Briefcase
View Summary Progenics Announces $50 Million RELISTOR® Royalty-Backed Financing
Nov 7, 2016
PDF 62.0 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Sets Third Quarter 2016 Financial Results Call for November 7
Oct 24, 2016
PDF 10.4 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at the 23rd Annual Prostate Cancer Foundation Scientific Retreat
Oct 21, 2016
PDF 10.6 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces Appointment of Bryce V. Tenbarge as Vice President of Commercial
Sep 7, 2016
PDF 11.1 KB Add to Briefcase
View Summary Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets
Sep 6, 2016
PDF 59.1 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at the 23rd Annual NewsMakers in the Biotech Industry Conference
Sep 2, 2016
PDF 10.4 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces Second Quarter 2016 Financial and Business Results
Aug 4, 2016
PDF 73.7 KB Add to Briefcase
View Summary Progenics Receives $50 Million Milestone Payment Following FDA Approval of RELISTOR® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain
Jul 26, 2016
PDF 60.3 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Sets Second Quarter 2016 Financial Results Call for August 4
Jul 22, 2016
PDF 10.4 KB Add to Briefcase
View Summary Valeant and Progenics Announce FDA Approves RELISTOR® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain
Jul 19, 2016
PDF 81.2 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
Jul 8, 2016
PDF 10.4 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces Presentations on its Prostate Cancer Imaging Programs at SNMMI 2016
Jun 13, 2016
PDF 12.4 KB Add to Briefcase
View Summary Bradley Campbell, President and COO of Amicus Therapeutics, elected to Progenics Board of Directors
Jun 9, 2016
PDF 11.2 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference
Jun 2, 2016
PDF 10.4 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Announces First Quarter 2016 Financial and Business Results
May 5, 2016
PDF 79.8 KB Add to Briefcase
View Summary Progenics Licenses PSMA Antibody Technology to Bayer for Development of Alpha-Radiolabeled Therapeutic Antibodies
May 2, 2016
PDF 7.7 KB Add to Briefcase
View Summary Progenics Pharmaceuticals Sets First Quarter 2016 Financial Results Call for May 5
Apr 21, 2016
PDF 10.5 KB Add to Briefcase
View Summary Progenics Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference
Apr 6, 2016
PDF 9.8 KB Add to Briefcase
Showing 1-20 of 272 Page: 1 2 3 4 5 ... 14  Next 20
Add to Briefcase = add release to Briefcase